| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | metalloendopeptidase activity | ADAMTS16 ADAMTS10 ADAMTS15 ADAMTS8 ADAMTS5 ADAMTS4 ADAMTS1 ADAMTS9 ADAMTSL2 | 4.73e-14 | 120 | 28 | 9 | GO:0004222 |
| GeneOntologyMolecularFunction | metallopeptidase activity | ADAMTS16 ADAMTS10 ADAMTS15 ADAMTS8 ADAMTS5 ADAMTS4 ADAMTS1 ADAMTS9 ADAMTSL2 | 4.96e-12 | 200 | 28 | 9 | GO:0008237 |
| GeneOntologyMolecularFunction | endopeptidase activity | ADAMTS16 ADAMTS10 ADAMTS15 ADAMTS8 ADAMTS5 ADAMTS4 ADAMTS1 ADAMTS9 ADAMTSL2 | 4.40e-09 | 430 | 28 | 9 | GO:0004175 |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 6.75e-08 | 268 | 28 | 7 | GO:0005539 | |
| GeneOntologyMolecularFunction | peptidase activity | ADAMTS16 ADAMTS10 ADAMTS15 ADAMTS8 ADAMTS5 ADAMTS4 ADAMTS1 ADAMTS9 ADAMTSL2 | 1.62e-07 | 654 | 28 | 9 | GO:0008233 |
| GeneOntologyMolecularFunction | heparin binding | 2.31e-07 | 192 | 28 | 6 | GO:0008201 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 2.40e-07 | 323 | 28 | 7 | GO:1901681 | |
| GeneOntologyMolecularFunction | extracellular matrix binding | 3.15e-06 | 73 | 28 | 4 | GO:0050840 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.31e-04 | 188 | 28 | 4 | GO:0005201 | |
| GeneOntologyMolecularFunction | semaphorin receptor binding | 4.71e-04 | 23 | 28 | 2 | GO:0030215 | |
| GeneOntologyMolecularFunction | chemorepellent activity | 7.52e-04 | 29 | 28 | 2 | GO:0045499 | |
| GeneOntologyMolecularFunction | zinc ion binding | 1.26e-03 | 891 | 28 | 6 | GO:0008270 | |
| GeneOntologyMolecularFunction | integrin binding | 1.85e-03 | 175 | 28 | 3 | GO:0005178 | |
| GeneOntologyMolecularFunction | lipopolysaccharide binding | 2.06e-03 | 48 | 28 | 2 | GO:0001530 | |
| GeneOntologyMolecularFunction | peptidase inhibitor activity | 2.23e-03 | 187 | 28 | 3 | GO:0030414 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 2.32e-03 | 51 | 28 | 2 | GO:0043394 | |
| GeneOntologyMolecularFunction | phosphatidylserine binding | 4.69e-03 | 73 | 28 | 2 | GO:0001786 | |
| GeneOntologyMolecularFunction | transition metal ion binding | 5.35e-03 | 1189 | 28 | 6 | GO:0046914 | |
| GeneOntologyMolecularFunction | peptidase regulator activity | 5.44e-03 | 257 | 28 | 3 | GO:0061134 | |
| GeneOntologyMolecularFunction | collagen binding | 5.74e-03 | 81 | 28 | 2 | GO:0005518 | |
| GeneOntologyMolecularFunction | modified amino acid binding | 1.26e-02 | 122 | 28 | 2 | GO:0072341 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | ADAMTS16 ADAMTS10 ADAMTS15 PAPLN SEMA5A ADAMTS8 ADAMTS5 HMCN1 ADAMTS4 ADAMTSL3 ADAMTS1 ADAMTS9 ADAMTSL2 | 6.05e-16 | 377 | 28 | 13 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | ADAMTS16 ADAMTS10 ADAMTS15 PAPLN SEMA5A ADAMTS8 ADAMTS5 HMCN1 ADAMTS4 ADAMTSL3 ADAMTS1 ADAMTS9 ADAMTSL2 | 6.26e-16 | 378 | 28 | 13 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | ADAMTS16 ADAMTS10 ADAMTS15 PAPLN SEMA5A ADAMTS8 ADAMTS5 HMCN1 ADAMTS4 ADAMTSL3 ADAMTS1 ADAMTS9 ADAMTSL2 | 6.48e-16 | 379 | 28 | 13 | GO:0045229 |
| GeneOntologyBiologicalProcess | extracellular matrix disassembly | 3.09e-06 | 75 | 28 | 4 | GO:0022617 | |
| GeneOntologyBiologicalProcess | cell recognition | 6.36e-06 | 198 | 28 | 5 | GO:0008037 | |
| GeneOntologyBiologicalProcess | negative regulation of multicellular organismal process | MTNR1B PLA2G5 SEMA5A THBS1 ADAMTS5 ING1 ADAMTS1 ADAMTS9 GP5 ADGRB1 | 1.46e-05 | 1488 | 28 | 10 | GO:0051241 |
| GeneOntologyBiologicalProcess | phagocytosis, recognition | 2.48e-05 | 42 | 28 | 3 | GO:0006910 | |
| GeneOntologyBiologicalProcess | negative regulation of cGMP-mediated signaling | 2.66e-05 | 6 | 28 | 2 | GO:0010754 | |
| GeneOntologyBiologicalProcess | positive regulation of axon extension involved in axon guidance | 3.72e-05 | 7 | 28 | 2 | GO:0048842 | |
| GeneOntologyBiologicalProcess | myoblast fusion | 6.58e-05 | 58 | 28 | 3 | GO:0007520 | |
| GeneOntologyBiologicalProcess | negative regulation of angiogenesis | 8.74e-05 | 175 | 28 | 4 | GO:0016525 | |
| GeneOntologyBiologicalProcess | negative regulation of blood vessel morphogenesis | 9.34e-05 | 178 | 28 | 4 | GO:2000181 | |
| GeneOntologyBiologicalProcess | negative regulation of vasculature development | 9.75e-05 | 180 | 28 | 4 | GO:1901343 | |
| GeneOntologyBiologicalProcess | ameboidal-type cell migration | 1.04e-04 | 577 | 28 | 6 | GO:0001667 | |
| GeneOntologyBiologicalProcess | response to bacterium | 1.74e-04 | 916 | 28 | 7 | GO:0009617 | |
| GeneOntologyBiologicalProcess | engulfment of apoptotic cell | 1.85e-04 | 15 | 28 | 2 | GO:0043652 | |
| GeneOntologyBiologicalProcess | regulation of cGMP-mediated signaling | 1.85e-04 | 15 | 28 | 2 | GO:0010752 | |
| GeneOntologyBiologicalProcess | cell-cell fusion | 2.05e-04 | 85 | 28 | 3 | GO:0140253 | |
| GeneOntologyBiologicalProcess | syncytium formation by plasma membrane fusion | 2.05e-04 | 85 | 28 | 3 | GO:0000768 | |
| GeneOntologyBiologicalProcess | regulation of angiogenesis | 2.28e-04 | 420 | 28 | 5 | GO:0045765 | |
| GeneOntologyBiologicalProcess | syncytium formation | 2.35e-04 | 89 | 28 | 3 | GO:0006949 | |
| GeneOntologyBiologicalProcess | regulation of axon extension involved in axon guidance | 2.39e-04 | 17 | 28 | 2 | GO:0048841 | |
| GeneOntologyBiologicalProcess | regulation of vasculature development | 2.54e-04 | 430 | 28 | 5 | GO:1901342 | |
| GeneOntologyBiologicalProcess | regulation of locomotion | 2.80e-04 | 1327 | 28 | 8 | GO:0040012 | |
| GeneOntologyBiologicalProcess | opsonization | 3.00e-04 | 19 | 28 | 2 | GO:0008228 | |
| GeneOntologyBiologicalProcess | negative regulation of locomotion | 3.27e-04 | 454 | 28 | 5 | GO:0040013 | |
| GeneOntologyBiologicalProcess | negative regulation of endothelial cell migration | 3.83e-04 | 105 | 28 | 3 | GO:0010596 | |
| GeneOntologyBiologicalProcess | axon extension involved in axon guidance | 4.04e-04 | 22 | 28 | 2 | GO:0048846 | |
| GeneOntologyBiologicalProcess | neuron projection extension involved in neuron projection guidance | 4.04e-04 | 22 | 28 | 2 | GO:1902284 | |
| GeneOntologyBiologicalProcess | tube development | 4.06e-04 | 1402 | 28 | 8 | GO:0035295 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell migration | 4.53e-04 | 269 | 28 | 4 | GO:0010594 | |
| GeneOntologyBiologicalProcess | phagocytosis | 4.85e-04 | 274 | 28 | 4 | GO:0006909 | |
| GeneOntologyBiologicalProcess | detection of light stimulus involved in visual perception | 5.23e-04 | 25 | 28 | 2 | GO:0050908 | |
| GeneOntologyBiologicalProcess | detection of light stimulus involved in sensory perception | 5.23e-04 | 25 | 28 | 2 | GO:0050962 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell chemotaxis | 5.66e-04 | 26 | 28 | 2 | GO:2001026 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | 6.07e-04 | 1125 | 28 | 7 | GO:0035239 | |
| GeneOntologyBiologicalProcess | negative regulation of epithelial cell migration | 6.37e-04 | 125 | 28 | 3 | GO:0010633 | |
| GeneOntologyBiologicalProcess | neuron projection fasciculation | 6.57e-04 | 28 | 28 | 2 | GO:0106030 | |
| GeneOntologyBiologicalProcess | axonal fasciculation | 6.57e-04 | 28 | 28 | 2 | GO:0007413 | |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | 6.76e-04 | 817 | 28 | 6 | GO:0048514 | |
| GeneOntologyBiologicalProcess | axon extension | 7.97e-04 | 135 | 28 | 3 | GO:0048675 | |
| GeneOntologyBiologicalProcess | negative regulation of sprouting angiogenesis | 8.60e-04 | 32 | 28 | 2 | GO:1903671 | |
| GeneOntologyBiologicalProcess | heart morphogenesis | 8.78e-04 | 321 | 28 | 4 | GO:0003007 | |
| GeneOntologyBiologicalProcess | regulation of cell migration | 9.40e-04 | 1211 | 28 | 7 | GO:0030334 | |
| GeneOntologyBiologicalProcess | endothelial cell migration | 9.84e-04 | 331 | 28 | 4 | GO:0043542 | |
| GeneOntologyBiologicalProcess | endothelial cell chemotaxis | 1.03e-03 | 35 | 28 | 2 | GO:0035767 | |
| GeneOntologyBiologicalProcess | regulation of epithelial cell migration | 1.13e-03 | 344 | 28 | 4 | GO:0010632 | |
| GeneOntologyBiologicalProcess | regulation of cell motility | 1.30e-03 | 1280 | 28 | 7 | GO:2000145 | |
| GeneOntologyBiologicalProcess | blood vessel development | 1.32e-03 | 929 | 28 | 6 | GO:0001568 | |
| GeneOntologyBiologicalProcess | cGMP-mediated signaling | 1.34e-03 | 40 | 28 | 2 | GO:0019934 | |
| GeneOntologyBiologicalProcess | myotube differentiation | 1.40e-03 | 164 | 28 | 3 | GO:0014902 | |
| GeneOntologyBiologicalProcess | positive regulation of chemotaxis | 1.45e-03 | 166 | 28 | 3 | GO:0050921 | |
| GeneOntologyBiologicalProcess | mesenchyme development | 1.51e-03 | 372 | 28 | 4 | GO:0060485 | |
| GeneOntologyBiologicalProcess | negative regulation of cell population proliferation | 1.57e-03 | 961 | 28 | 6 | GO:0008285 | |
| GeneOntologyBiologicalProcess | vasculature development | 1.64e-03 | 969 | 28 | 6 | GO:0001944 | |
| GeneOntologyBiologicalProcess | apoptotic cell clearance | 1.93e-03 | 48 | 28 | 2 | GO:0043277 | |
| GeneOntologyBiologicalProcess | defense response to bacterium | 2.06e-03 | 405 | 28 | 4 | GO:0042742 | |
| GeneOntologyBiologicalProcess | negative chemotaxis | 2.17e-03 | 51 | 28 | 2 | GO:0050919 | |
| GeneOntologyBiologicalProcess | regulation of transforming growth factor beta receptor signaling pathway | 2.19e-03 | 192 | 28 | 3 | GO:0017015 | |
| GeneOntologyBiologicalProcess | semaphorin-plexin signaling pathway | 2.26e-03 | 52 | 28 | 2 | GO:0071526 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to transforming growth factor beta stimulus | 2.29e-03 | 195 | 28 | 3 | GO:1903844 | |
| GeneOntologyBiologicalProcess | negative regulation of cell migration | 2.34e-03 | 419 | 28 | 4 | GO:0030336 | |
| GeneOntologyBiologicalProcess | angiogenesis | 2.40e-03 | 708 | 28 | 5 | GO:0001525 | |
| GeneOntologyBiologicalProcess | negative regulation of chemotaxis | 2.43e-03 | 54 | 28 | 2 | GO:0050922 | |
| GeneOntologyBiologicalProcess | blood vessel endothelial cell proliferation involved in sprouting angiogenesis | 2.52e-03 | 55 | 28 | 2 | GO:0002043 | |
| GeneOntologyBiologicalProcess | positive regulation of axon extension | 2.52e-03 | 55 | 28 | 2 | GO:0045773 | |
| GeneOntologyBiologicalProcess | circulatory system development | 2.59e-03 | 1442 | 28 | 7 | GO:0072359 | |
| GeneOntologyBiologicalProcess | epithelial cell migration | 2.61e-03 | 432 | 28 | 4 | GO:0010631 | |
| GeneOntologyBiologicalProcess | negative regulation of cell motility | 2.67e-03 | 435 | 28 | 4 | GO:2000146 | |
| GeneOntologyBiologicalProcess | epithelium migration | 2.67e-03 | 435 | 28 | 4 | GO:0090132 | |
| GeneOntologyBiologicalProcess | detection of visible light | 2.71e-03 | 57 | 28 | 2 | GO:0009584 | |
| GeneOntologyBiologicalProcess | neuron projection extension | 2.71e-03 | 207 | 28 | 3 | GO:1990138 | |
| GeneOntologyBiologicalProcess | endocardial cushion development | 2.80e-03 | 58 | 28 | 2 | GO:0003197 | |
| GeneOntologyBiologicalProcess | tissue migration | 2.81e-03 | 441 | 28 | 4 | GO:0090130 | |
| GeneOntologyBiologicalProcess | neuron recognition | 2.90e-03 | 59 | 28 | 2 | GO:0008038 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 2.90e-03 | 445 | 28 | 4 | GO:0141091 | |
| GeneOntologyBiologicalProcess | positive regulation of locomotion | 2.94e-03 | 742 | 28 | 5 | GO:0040017 | |
| GeneOntologyBiologicalProcess | regulation of anatomical structure morphogenesis | 2.97e-03 | 1090 | 28 | 6 | GO:0022603 | |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | 3.03e-03 | 1483 | 28 | 7 | GO:0048646 | |
| GeneOntologyBiologicalProcess | neural crest cell migration | 3.20e-03 | 62 | 28 | 2 | GO:0001755 | |
| GeneOntologyBiologicalProcess | heart development | 3.20e-03 | 757 | 28 | 5 | GO:0007507 | |
| GeneOntologyBiologicalProcess | sprouting angiogenesis | 3.22e-03 | 220 | 28 | 3 | GO:0002040 | |
| GeneOntologyBiologicalProcess | heart valve morphogenesis | 3.30e-03 | 63 | 28 | 2 | GO:0003179 | |
| GeneOntologyBiologicalProcess | mesenchymal cell migration | 3.40e-03 | 64 | 28 | 2 | GO:0090497 | |
| GeneOntologyBiologicalProcess | visual perception | 3.65e-03 | 230 | 28 | 3 | GO:0007601 | |
| GeneOntologyBiologicalProcess | sensory perception of light stimulus | 3.78e-03 | 233 | 28 | 3 | GO:0050953 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | 3.86e-03 | 482 | 28 | 4 | GO:0007178 | |
| GeneOntologyBiologicalProcess | negative regulation of blood coagulation | 3.94e-03 | 69 | 28 | 2 | GO:0030195 | |
| GeneOntologyBiologicalProcess | phagocytosis, engulfment | 3.94e-03 | 69 | 28 | 2 | GO:0006911 | |
| GeneOntologyBiologicalProcess | smooth muscle cell proliferation | 3.97e-03 | 237 | 28 | 3 | GO:0048659 | |
| GeneOntologyBiologicalProcess | negative regulation of hemostasis | 4.05e-03 | 70 | 28 | 2 | GO:1900047 | |
| GeneOntologyCellularComponent | extracellular matrix | ADAMTS16 ADAMTS10 ADAMTS15 PAPLN THBS1 ADAMTS8 ADAMTS5 HMCN1 ADAMTS4 ADAMTSL3 ADAMTS1 ADAMTS9 SSPOP SPON2 ADAMTSL2 | 2.95e-16 | 656 | 27 | 15 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | ADAMTS16 ADAMTS10 ADAMTS15 PAPLN THBS1 ADAMTS8 ADAMTS5 HMCN1 ADAMTS4 ADAMTSL3 ADAMTS1 ADAMTS9 SSPOP SPON2 ADAMTSL2 | 3.09e-16 | 658 | 27 | 15 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | ADAMTS10 ADAMTS15 PAPLN THBS1 ADAMTS8 ADAMTS5 HMCN1 ADAMTS4 ADAMTS1 ADAMTS9 SSPOP | 2.27e-11 | 530 | 27 | 11 | GO:0062023 |
| GeneOntologyCellularComponent | basement membrane | 5.12e-04 | 122 | 27 | 3 | GO:0005604 | |
| GeneOntologyCellularComponent | cell surface | 2.51e-03 | 1111 | 27 | 6 | GO:0009986 | |
| Domain | TSP_1 | ADAMTS16 ADAMTS10 ADAMTS15 PAPLN SEMA5A THBS1 ADAMTS8 ADAMTS5 HMCN1 ADAMTS4 ADAMTSL3 SEMA5B ADAMTS1 ADAMTS9 SSPOP SPON2 ADAMTSL2 ADGRB1 | 1.00e-39 | 63 | 27 | 18 | PF00090 |
| Domain | TSP1 | ADAMTS16 ADAMTS10 ADAMTS15 PAPLN SEMA5A THBS1 ADAMTS8 ADAMTS5 HMCN1 ADAMTS4 ADAMTSL3 SEMA5B ADAMTS1 ADAMTS9 SSPOP SPON2 ADAMTSL2 ADGRB1 | 1.93e-39 | 65 | 27 | 18 | SM00209 |
| Domain | TSP1_rpt | ADAMTS16 ADAMTS10 ADAMTS15 PAPLN SEMA5A THBS1 ADAMTS8 ADAMTS5 HMCN1 ADAMTS4 ADAMTSL3 SEMA5B ADAMTS1 ADAMTS9 SSPOP SPON2 ADAMTSL2 ADGRB1 | 1.93e-39 | 65 | 27 | 18 | IPR000884 |
| Domain | TSP1 | ADAMTS16 ADAMTS10 ADAMTS15 PAPLN SEMA5A THBS1 ADAMTS8 ADAMTS5 HMCN1 ADAMTS4 ADAMTSL3 SEMA5B ADAMTS1 ADAMTS9 SSPOP SPON2 ADAMTSL2 ADGRB1 | 1.93e-39 | 65 | 27 | 18 | PS50092 |
| Domain | Peptidase_M12B_ADAM-TS | ADAMTS16 ADAMTS10 ADAMTS15 PAPLN ADAMTS8 ADAMTS5 ADAMTS4 ADAMTSL3 ADAMTS1 ADAMTS9 ADAMTSL2 | 1.34e-26 | 24 | 27 | 11 | IPR013273 |
| Domain | ADAM_spacer1 | ADAMTS16 ADAMTS10 ADAMTS15 PAPLN ADAMTS8 ADAMTS5 ADAMTS4 ADAMTS1 ADAMTS9 ADAMTSL2 | 6.72e-24 | 23 | 27 | 10 | IPR010294 |
| Domain | ADAM_spacer1 | ADAMTS16 ADAMTS10 ADAMTS15 PAPLN ADAMTS8 ADAMTS5 ADAMTS4 ADAMTS1 ADAMTS9 ADAMTSL2 | 6.72e-24 | 23 | 27 | 10 | PF05986 |
| Domain | Peptidase_M12B_N | ADAMTS16 ADAMTS10 ADAMTS15 ADAMTS8 ADAMTS5 ADAMTS4 ADAMTS1 ADAMTS9 | 3.62e-16 | 39 | 27 | 8 | IPR002870 |
| Domain | Pep_M12B_propep | ADAMTS16 ADAMTS10 ADAMTS15 ADAMTS8 ADAMTS5 ADAMTS4 ADAMTS1 ADAMTS9 | 3.62e-16 | 39 | 27 | 8 | PF01562 |
| Domain | DISINTEGRIN_1 | ADAMTS16 ADAMTS10 ADAMTS15 ADAMTS8 ADAMTS5 ADAMTS4 ADAMTS1 ADAMTS9 | 4.52e-16 | 40 | 27 | 8 | PS00427 |
| Domain | ADAM_MEPRO | ADAMTS16 ADAMTS10 ADAMTS15 ADAMTS8 ADAMTS5 ADAMTS4 ADAMTS1 ADAMTS9 | 4.52e-16 | 40 | 27 | 8 | PS50215 |
| Domain | DISINTEGRIN_2 | ADAMTS16 ADAMTS10 ADAMTS15 ADAMTS8 ADAMTS5 ADAMTS4 ADAMTS1 ADAMTS9 | 4.52e-16 | 40 | 27 | 8 | PS50214 |
| Domain | Reprolysin | ADAMTS16 ADAMTS10 ADAMTS15 ADAMTS8 ADAMTS5 ADAMTS4 ADAMTS1 ADAMTS9 | 4.52e-16 | 40 | 27 | 8 | PF01421 |
| Domain | Peptidase_M12B | ADAMTS16 ADAMTS10 ADAMTS15 ADAMTS8 ADAMTS5 ADAMTS4 ADAMTS1 ADAMTS9 | 4.52e-16 | 40 | 27 | 8 | IPR001590 |
| Domain | Disintegrin_dom | ADAMTS16 ADAMTS10 ADAMTS15 ADAMTS8 ADAMTS5 ADAMTS4 ADAMTS1 ADAMTS9 | 5.61e-16 | 41 | 27 | 8 | IPR001762 |
| Domain | MetalloPept_cat_dom | ADAMTS16 ADAMTS10 ADAMTS15 ADAMTS8 ADAMTS5 ADAMTS4 ADAMTS1 ADAMTS9 | 1.82e-13 | 81 | 27 | 8 | IPR024079 |
| Domain | - | ADAMTS16 ADAMTS10 ADAMTS15 ADAMTS8 ADAMTS5 ADAMTS4 ADAMTS1 ADAMTS9 | 1.82e-13 | 81 | 27 | 8 | 3.40.390.10 |
| Domain | ZINC_PROTEASE | ADAMTS16 ADAMTS10 ADAMTS15 ADAMTS8 ADAMTS5 ADAMTS4 ADAMTS1 ADAMTS9 | 8.78e-13 | 98 | 27 | 8 | PS00142 |
| Domain | PLAC | 8.46e-12 | 14 | 27 | 5 | PF08686 | |
| Domain | PLAC | 4.89e-11 | 19 | 27 | 5 | IPR010909 | |
| Domain | PLAC | 4.89e-11 | 19 | 27 | 5 | PS50900 | |
| Domain | ADAM_Cys-rich | 3.37e-10 | 27 | 27 | 5 | IPR006586 | |
| Domain | ACR | 3.37e-10 | 27 | 27 | 5 | SM00608 | |
| Domain | Pept_M12B_ADAM-TS8 | 2.01e-06 | 2 | 27 | 2 | IPR013277 | |
| Domain | Plexin_repeat | 1.30e-05 | 32 | 27 | 3 | IPR002165 | |
| Domain | PSI | 1.30e-05 | 32 | 27 | 3 | PF01437 | |
| Domain | CYSTEINE_SWITCH | 2.77e-05 | 41 | 27 | 3 | PS00546 | |
| Domain | Pept_M10_metallopeptidase | 3.20e-05 | 43 | 27 | 3 | IPR001818 | |
| Domain | PSI | 3.43e-05 | 44 | 27 | 3 | IPR016201 | |
| Domain | PSI | 3.92e-05 | 46 | 27 | 3 | SM00423 | |
| Domain | Ig_I-set | 1.52e-04 | 190 | 27 | 4 | IPR013098 | |
| Domain | I-set | 1.52e-04 | 190 | 27 | 4 | PF07679 | |
| Domain | EGF_CA | 2.55e-04 | 86 | 27 | 3 | PF07645 | |
| Domain | EGF_3 | 3.41e-04 | 235 | 27 | 4 | PS50026 | |
| Domain | IGc2 | 3.41e-04 | 235 | 27 | 4 | SM00408 | |
| Domain | Ig_sub2 | 3.41e-04 | 235 | 27 | 4 | IPR003598 | |
| Domain | Semaphorin | 3.76e-04 | 20 | 27 | 2 | IPR027231 | |
| Domain | EGF_1 | 4.65e-04 | 255 | 27 | 4 | PS00022 | |
| Domain | EGF_2 | 5.38e-04 | 265 | 27 | 4 | PS01186 | |
| Domain | EGF_CA | 7.09e-04 | 122 | 27 | 3 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 7.44e-04 | 124 | 27 | 3 | IPR001881 | |
| Domain | SEMA | 9.12e-04 | 31 | 27 | 2 | PS51004 | |
| Domain | Sema | 9.12e-04 | 31 | 27 | 2 | SM00630 | |
| Domain | Semap_dom | 9.12e-04 | 31 | 27 | 2 | IPR001627 | |
| Domain | Sema | 9.12e-04 | 31 | 27 | 2 | PF01403 | |
| Domain | VWFC_1 | 1.23e-03 | 36 | 27 | 2 | PS01208 | |
| Domain | VWC | 1.37e-03 | 38 | 27 | 2 | SM00214 | |
| Domain | VWFC_2 | 1.37e-03 | 38 | 27 | 2 | PS50184 | |
| Domain | VWF_dom | 1.67e-03 | 42 | 27 | 2 | IPR001007 | |
| Domain | IG | 2.96e-03 | 421 | 27 | 4 | SM00409 | |
| Domain | Ig_sub | 2.96e-03 | 421 | 27 | 4 | IPR003599 | |
| Domain | EGF | 4.60e-03 | 235 | 27 | 3 | SM00181 | |
| Domain | IG_LIKE | 5.12e-03 | 491 | 27 | 4 | PS50835 | |
| Domain | IGv | 5.23e-03 | 75 | 27 | 2 | SM00406 | |
| Domain | EGF-like_dom | 5.41e-03 | 249 | 27 | 3 | IPR000742 | |
| Domain | Ig-like_dom | 5.58e-03 | 503 | 27 | 4 | IPR007110 | |
| Domain | EGF-like_CS | 6.16e-03 | 261 | 27 | 3 | IPR013032 | |
| Domain | EGF_Ca-bd_CS | 8.61e-03 | 97 | 27 | 2 | IPR018097 | |
| Domain | EGF_CA | 8.96e-03 | 99 | 27 | 2 | PS01187 | |
| Domain | ASX_HYDROXYL | 9.13e-03 | 100 | 27 | 2 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.02e-02 | 106 | 27 | 2 | IPR000152 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | ADAMTS16 ADAMTS10 ADAMTS15 SEMA5A THBS1 ADAMTS8 ADAMTS5 ADAMTS4 ADAMTSL3 SEMA5B ADAMTS1 ADAMTS9 SSPOP SPON2 ADAMTSL2 | 3.24e-35 | 39 | 22 | 15 | MM15165 |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | ADAMTS16 ADAMTS10 ADAMTS15 SEMA5A THBS1 ADAMTS8 ADAMTS5 ADAMTS4 ADAMTSL3 SEMA5B ADAMTS1 ADAMTS9 SSPOP SPON2 ADAMTSL2 | 3.24e-35 | 39 | 22 | 15 | M27417 |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | ADAMTS16 ADAMTS10 ADAMTS15 SEMA5A THBS1 ADAMTS8 ADAMTS5 ADAMTS4 ADAMTSL3 SEMA5B ADAMTS1 ADAMTS9 SSPOP SPON2 ADAMTSL2 | 5.64e-31 | 68 | 22 | 15 | M27303 |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | ADAMTS16 ADAMTS10 ADAMTS15 SEMA5A THBS1 ADAMTS8 ADAMTS5 ADAMTS4 ADAMTSL3 SEMA5B ADAMTS1 ADAMTS9 SSPOP SPON2 ADAMTSL2 | 1.27e-27 | 109 | 22 | 15 | MM15164 |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | ADAMTS16 ADAMTS10 ADAMTS15 SEMA5A THBS1 ADAMTS8 ADAMTS5 ADAMTS4 ADAMTSL3 SEMA5B ADAMTS1 ADAMTS9 SSPOP SPON2 ADAMTSL2 | 1.69e-27 | 111 | 22 | 15 | M27416 |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | ADAMTS16 ADAMTS10 ADAMTS15 SEMA5A THBS1 ADAMTS8 ADAMTS5 ADAMTS4 ADAMTSL3 SEMA5B ADAMTS1 ADAMTS9 SSPOP SPON2 ADAMTSL2 | 9.37e-26 | 143 | 22 | 15 | M27275 |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | ADAMTS16 ADAMTS10 ADAMTS15 SEMA5A THBS1 ADAMTS8 ADAMTS5 ADAMTS4 ADAMTSL3 SEMA5B ADAMTS1 ADAMTS9 SSPOP SPON2 ADAMTSL2 | 5.41e-22 | 250 | 22 | 15 | M27554 |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | ADAMTS16 ADAMTS10 ADAMTS15 SEMA5A THBS1 ADAMTS8 ADAMTS5 FAM86C1P ADAMTS4 ADAMTSL3 SEMA5B ADAMTS1 ADAMTS9 SSPOP SPON2 ADAMTSL2 | 3.06e-12 | 1389 | 22 | 16 | MM15307 |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | ADAMTS16 ADAMTS10 ADAMTS15 SEMA5A THBS1 ADAMTS8 ADAMTS5 ADAMTS4 ADAMTSL3 SEMA5B ADAMTS1 ADAMTS9 SSPOP SPON2 ADAMTSL2 | 1.54e-10 | 1475 | 22 | 15 | M19806 |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 5.64e-08 | 140 | 22 | 6 | M587 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 2.39e-07 | 300 | 22 | 7 | M610 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS | 1.01e-04 | 59 | 22 | 3 | M39886 | |
| Pathway | WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS | 1.23e-04 | 63 | 22 | 3 | M39884 | |
| Pathway | WP_ENDOCHONDRAL_OSSIFICATION | 1.23e-04 | 63 | 22 | 3 | M39646 | |
| Pathway | WP_ENDOCHONDRAL_OSSIFICATION | 1.42e-04 | 66 | 22 | 3 | MM15875 | |
| Pubmed | ADAMTS16 ADAMTS10 ADAMTS15 PAPLN SEMA5A THBS1 ADAMTS8 ADAMTS5 HMCN1 ADAMTS4 ADAMTSL3 SEMA5B ADAMTS1 ADAMTS9 SSPOP ADAMTSL2 ADGRB1 | 1.40e-39 | 75 | 28 | 17 | 20637190 | |
| Pubmed | 2.32e-16 | 5 | 28 | 5 | 22562232 | ||
| Pubmed | 5.90e-15 | 20 | 28 | 6 | 19922873 | ||
| Pubmed | Insights on ADAMTS proteases and ADAMTS-like proteins from mammalian genetics. | 1.83e-13 | 12 | 28 | 5 | 25770910 | |
| Pubmed | 1.01e-12 | 16 | 28 | 5 | 30579834 | ||
| Pubmed | 4.33e-12 | 210 | 28 | 8 | 16537572 | ||
| Pubmed | 1.17e-11 | 7 | 28 | 4 | 15599946 | ||
| Pubmed | 2.35e-11 | 8 | 28 | 4 | 23233679 | ||
| Pubmed | 7.03e-11 | 10 | 28 | 4 | 11167130 | ||
| Pubmed | Endocardial Brg1 represses ADAMTS1 to maintain the microenvironment for myocardial morphogenesis. | 1.14e-10 | 38 | 28 | 5 | 18267097 | |
| Pubmed | 2.39e-10 | 13 | 28 | 4 | 32909945 | ||
| Pubmed | 4.67e-10 | 3 | 28 | 3 | 15659705 | ||
| Pubmed | 4.67e-10 | 3 | 28 | 3 | 21345877 | ||
| Pubmed | 4.67e-10 | 3 | 28 | 3 | 23562508 | ||
| Pubmed | 4.67e-10 | 3 | 28 | 3 | 23859810 | ||
| Pubmed | 7.94e-10 | 17 | 28 | 4 | 22183742 | ||
| Pubmed | 1.71e-09 | 64 | 28 | 5 | 22261194 | ||
| Pubmed | 1.87e-09 | 4 | 28 | 3 | 24220035 | ||
| Pubmed | 1.87e-09 | 4 | 28 | 3 | 16507336 | ||
| Pubmed | Expression of ADAMTS-1, ADAMTS-4, ADAMTS-5 and TIMP3 by hepatocellular carcinoma cell lines. | 1.87e-09 | 4 | 28 | 3 | 22735305 | |
| Pubmed | 3.53e-09 | 24 | 28 | 4 | 29791855 | ||
| Pubmed | 4.67e-09 | 5 | 28 | 3 | 25349050 | ||
| Pubmed | 4.67e-09 | 5 | 28 | 3 | 11831030 | ||
| Pubmed | Proteolytic cleavage of versican during cardiac cushion morphogenesis. | 9.33e-09 | 6 | 28 | 3 | 16691565 | |
| Pubmed | 1.63e-08 | 7 | 28 | 3 | 23354118 | ||
| Pubmed | Galnt1 is required for normal heart valve development and cardiac function. | 1.94e-08 | 36 | 28 | 4 | 25615642 | |
| Pubmed | Control of cardiac jelly dynamics by NOTCH1 and NRG1 defines the building plan for trabeculation. | 2.43e-08 | 38 | 28 | 4 | 29743679 | |
| Pubmed | 2.61e-08 | 8 | 28 | 3 | 21041365 | ||
| Pubmed | Zinc transporter Slc39a8 is essential for cardiac ventricular compaction. | 7.68e-08 | 11 | 28 | 3 | 29337306 | |
| Pubmed | Cerebral cavernous malformations are driven by ADAMTS5 proteolysis of versican. | 1.02e-07 | 12 | 28 | 3 | 32648916 | |
| Pubmed | PIBF1 regulates trophoblast syncytialization and promotes cardiovascular development. | 1.48e-07 | 59 | 28 | 4 | 38374152 | |
| Pubmed | 3.15e-07 | 17 | 28 | 3 | 10464288 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 25477257 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 30446843 | ||
| Pubmed | Lentiviral shRNA knock-down of ADAMTS-5 and -9 restores matrix deposition in 3D chondrocyte culture. | 6.25e-07 | 2 | 28 | 2 | 20568084 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 16003758 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 17938173 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 32067610 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 29137610 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 24786121 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 25101296 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 17978660 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 26888488 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 30369484 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 10438512 | ||
| Pubmed | Cloning and characterization of ADAMTS11, an aggrecanase from the ADAMTS family. | 6.25e-07 | 2 | 28 | 2 | 10438522 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 31734379 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 29926003 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 23154421 | ||
| Pubmed | ADAMTS1 alters blood vessel morphology and TSP1 levels in LNCaP and LNCaP-19 prostate tumors. | 6.25e-07 | 2 | 28 | 2 | 20546609 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 39122105 | ||
| Pubmed | ADAMTS1 mediates the release of antiangiogenic polypeptides from TSP1 and 2. | 6.25e-07 | 2 | 28 | 2 | 17082774 | |
| Pubmed | ADAMTS8 and ADAMTS15 expression predicts survival in human breast carcinoma. | 6.25e-07 | 2 | 28 | 2 | 16152618 | |
| Pubmed | Expression and regulation of aggrecanase in arthritis: the role of TGF-beta. | 6.25e-07 | 2 | 28 | 2 | 11801682 | |
| Pubmed | Crystal structures of the two major aggrecan degrading enzymes, ADAMTS4 and ADAMTS5. | 6.25e-07 | 2 | 28 | 2 | 18042673 | |
| Pubmed | Inhibition of ADAM-TS4 and ADAM-TS5 prevents aggrecan degradation in osteoarthritic cartilage. | 6.25e-07 | 2 | 28 | 2 | 11956193 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 29737873 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 18156631 | ||
| Pubmed | ADAMTS proteoglycanases downregulation with impaired oocyte quality in PCOS. | 6.25e-07 | 2 | 28 | 2 | 33444494 | |
| Pubmed | The role of ADAMTS genes in the end stage of hip osteoarthritis. | 6.25e-07 | 2 | 28 | 2 | 30655094 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 27706574 | ||
| Pubmed | Structure analysis reveals the flexibility of the ADAMTS-5 active site. | 6.25e-07 | 2 | 28 | 2 | 21370305 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 17255106 | ||
| Pubmed | ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro. | 6.25e-07 | 2 | 28 | 2 | 15800625 | |
| Pubmed | Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. | 6.25e-07 | 2 | 28 | 2 | 15800624 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 32490633 | ||
| Pubmed | Proteolytic activities of human ADAMTS-5: comparative studies with ADAMTS-4. | 6.25e-07 | 2 | 28 | 2 | 17430884 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 17968948 | ||
| Pubmed | Development of human neutralizing antibody to ADAMTS4 (aggrecanase-1) and ADAMTS5 (aggrecanase-2). | 6.25e-07 | 2 | 28 | 2 | 26612259 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 17265492 | ||
| Pubmed | 8.19e-07 | 23 | 28 | 3 | 29567669 | ||
| Pubmed | Differential gene expression of ADAMTS-1, ADAMTS-9 and TIMP-3 in periodontitis. | 1.87e-06 | 3 | 28 | 2 | 36093887 | |
| Pubmed | Proprotein convertase activation of aggrecanases in cartilage in situ. | 1.87e-06 | 3 | 28 | 2 | 18671934 | |
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 14667842 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 24474687 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 28099917 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 11278559 | ||
| Pubmed | Sox4 is involved in osteoarthritic cartilage deterioration through induction of ADAMTS4 and ADAMTS5. | 1.87e-06 | 3 | 28 | 2 | 30016600 | |
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 24753090 | ||
| Pubmed | Cochlin produced by follicular dendritic cells promotes antibacterial innate immunity. | 1.87e-06 | 3 | 28 | 2 | 23684986 | |
| Pubmed | Differentially regulated ADAMTS1, 8, and 18 in gastric adenocarcinoma. | 1.87e-06 | 3 | 28 | 2 | 28814085 | |
| Pubmed | The C-terminal domains of ADAMTS-4 and ADAMTS-5 promote association with N-TIMP-3. | 1.87e-06 | 3 | 28 | 2 | 19643179 | |
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 25510509 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 28323982 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 14715656 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 24732836 | ||
| Pubmed | Determinants of versican-V1 proteoglycan processing by the metalloproteinase ADAMTS5. | 1.87e-06 | 3 | 28 | 2 | 25122765 | |
| Pubmed | Progesterone acts via the progesterone receptor to induce adamts proteases in ovarian cancer cells. | 1.87e-06 | 3 | 28 | 2 | 26916548 | |
| Pubmed | Semaphorin 3E/PlexinD1 signaling is required for cardiac ventricular compaction. | 2.28e-06 | 32 | 28 | 3 | 31434798 | |
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 30730845 | ||
| Pubmed | ADAMTS: a novel family of proteases with an ADAM protease domain and thrombospondin 1 repeats. | 3.75e-06 | 4 | 28 | 2 | 10094461 | |
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 17606262 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 23082219 | ||
| Pubmed | Proteolytic cleavage of versican during limb joint development. | 3.75e-06 | 4 | 28 | 2 | 20101710 | |
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 11854269 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 21584905 | ||
| Pubmed | ADAMTS 1, 4, 12, and 13 levels in maternal blood, cord blood, and placenta in preeclampsia. | 3.75e-06 | 4 | 28 | 2 | 29135310 | |
| Pubmed | Metalloproteinase Adamts16 Is Required for Proper Closure of the Optic Fissure. | 6.24e-06 | 5 | 28 | 2 | 29625437 | |
| Pubmed | 6.24e-06 | 5 | 28 | 2 | 8817451 | ||
| Pubmed | 6.24e-06 | 5 | 28 | 2 | 29758265 | ||
| Interaction | ACAN interactions | 3.25e-06 | 22 | 27 | 3 | int:ACAN | |
| Interaction | ADAMTS8 interactions | 1.72e-05 | 5 | 27 | 2 | int:ADAMTS8 | |
| Interaction | ADAMTS15 interactions | 1.13e-04 | 12 | 27 | 2 | int:ADAMTS15 | |
| Interaction | ADAMTS4 interactions | 1.20e-04 | 72 | 27 | 3 | int:ADAMTS4 | |
| Interaction | DCAF6 interactions | 2.03e-04 | 221 | 27 | 4 | int:DCAF6 | |
| Cytoband | 11q25 | 1.16e-04 | 26 | 28 | 2 | 11q25 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr21q21 | 2.53e-03 | 122 | 28 | 2 | chr21q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q24 | 6.06e-03 | 191 | 28 | 2 | chr11q24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5p15 | 6.88e-03 | 204 | 28 | 2 | chr5p15 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | ADAMTS16 ADAMTS10 ADAMTS15 ADAMTS8 ADAMTS5 ADAMTS4 ADAMTS1 ADAMTS9 | 8.48e-20 | 19 | 22 | 8 | 50 |
| GeneFamily | ADAMTS like | 5.46e-08 | 7 | 22 | 3 | 947 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 3.91e-05 | 161 | 22 | 4 | 593 | |
| GeneFamily | Immunoglobulin like domain containing|Semaphorins | 2.65e-04 | 20 | 22 | 2 | 736 | |
| GeneFamily | Immunoglobulin like domain containing | 2.28e-02 | 193 | 22 | 2 | 594 | |
| Coexpression | NABA_MATRISOME | ADAMTS16 ADAMTS10 ADAMTS15 PAPLN SEMA5A THBS1 ADAMTS8 ADAMTS5 HMCN1 MEGF8 ADAMTS4 ADAMTSL3 SEMA5B ADAMTS1 ADAMTS9 SSPOP SPON2 ADAMTSL2 | 2.66e-19 | 1008 | 28 | 18 | MM17056 |
| Coexpression | NABA_MATRISOME | ADAMTS16 ADAMTS10 ADAMTS15 PAPLN SEMA5A THBS1 ADAMTS8 ADAMTS5 HMCN1 MEGF8 ADAMTS4 ADAMTSL3 SEMA5B ADAMTS1 ADAMTS9 SSPOP SPON2 ADAMTSL2 | 3.65e-19 | 1026 | 28 | 18 | M5889 |
| Coexpression | NABA_ECM_REGULATORS | ADAMTS16 ADAMTS10 ADAMTS15 ADAMTS8 ADAMTS5 ADAMTS4 ADAMTSL3 ADAMTS1 ADAMTS9 ADAMTSL2 | 3.58e-14 | 238 | 28 | 10 | M3468 |
| Coexpression | NABA_ECM_REGULATORS | ADAMTS16 ADAMTS10 ADAMTS15 ADAMTS8 ADAMTS5 ADAMTS4 ADAMTSL3 ADAMTS1 ADAMTS9 ADAMTSL2 | 4.24e-14 | 242 | 28 | 10 | MM17062 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | ADAMTS16 ADAMTS10 ADAMTS15 SEMA5A ADAMTS8 ADAMTS5 MEGF8 ADAMTS4 ADAMTSL3 SEMA5B ADAMTS1 ADAMTS9 ADAMTSL2 | 1.60e-13 | 738 | 28 | 13 | MM17058 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | ADAMTS16 ADAMTS10 ADAMTS15 SEMA5A ADAMTS8 ADAMTS5 MEGF8 ADAMTS4 ADAMTSL3 SEMA5B ADAMTS1 ADAMTS9 ADAMTSL2 | 1.99e-13 | 751 | 28 | 13 | M5885 |
| Coexpression | DESCARTES_MAIN_FETAL_IGFBP1_DKK1_POSITIVE_CELLS | 1.25e-06 | 180 | 28 | 5 | M40135 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.67e-06 | 191 | 28 | 5 | MM17059 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_PERICYTE | 1.85e-06 | 195 | 28 | 5 | M45684 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.90e-06 | 196 | 28 | 5 | M3008 | |
| Coexpression | DESCARTES_FETAL_PLACENTA_SMOOTH_MUSCLE_CELLS | 2.39e-06 | 89 | 28 | 4 | M40280 | |
| Coexpression | NABA_CORE_MATRISOME | 9.05e-06 | 270 | 28 | 5 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 9.89e-06 | 275 | 28 | 5 | M5884 | |
| Coexpression | KATSANOU_ELAVL1_TARGETS_UP | 3.32e-05 | 173 | 28 | 4 | M2385 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_COLORECTAL_TUMOR | 3.41e-05 | 59 | 28 | 3 | M47989 | |
| Coexpression | GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_C57BL6_DN | 3.55e-05 | 176 | 28 | 4 | M8790 | |
| Coexpression | GSE29614_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_UP | 4.59e-05 | 188 | 28 | 4 | M4908 | |
| Coexpression | KATSANOU_ELAVL1_TARGETS_UP | 4.59e-05 | 188 | 28 | 4 | MM1071 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN | 6.75e-05 | 411 | 28 | 5 | M1351 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN | 7.15e-05 | 416 | 28 | 5 | MM1002 | |
| Coexpression | INAMURA_LUNG_CANCER_SCC_DN | 8.52e-05 | 13 | 28 | 2 | M1255 | |
| Coexpression | TRAVAGLINI_LUNG_BRONCHIAL_VESSEL_1_CELL | 9.05e-05 | 224 | 28 | 4 | M41668 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_AEROCYTE | 1.09e-04 | 87 | 28 | 3 | M45745 | |
| Coexpression | DESCARTES_FETAL_EYE_STROMAL_CELLS | 1.25e-04 | 91 | 28 | 3 | M40180 | |
| Coexpression | GAO_LARGE_INTESTINE_24W_C1_DCLK1POS_PROGENITOR | 1.60e-04 | 99 | 28 | 3 | M39152 | |
| Coexpression | GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_UP | 1.67e-04 | 18 | 28 | 2 | M19133 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_MID_SCHWANN_CELL | 1.80e-04 | 268 | 28 | 4 | M45796 | |
| Coexpression | ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN | 1.96e-04 | 106 | 28 | 3 | M9160 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_LATE_AIRWAY_SMC_CELL | 2.49e-04 | 115 | 28 | 3 | M45671 | |
| Coexpression | AIZARANI_LIVER_C20_LSECS_3 | 2.60e-04 | 295 | 28 | 4 | M39121 | |
| Coexpression | HOELZEL_NF1_TARGETS_DN | 2.68e-04 | 118 | 28 | 3 | M2143 | |
| Coexpression | DESCARTES_FETAL_PLACENTA_IGFBP1_DKK1_POSITIVE_CELLS | 2.68e-04 | 118 | 28 | 3 | M40281 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_VASCULAR_SMC_1_CELL | 3.10e-04 | 124 | 28 | 3 | M45686 | |
| Coexpression | AIZARANI_LIVER_C33_STELLATE_CELLS_2 | 3.25e-04 | 126 | 28 | 3 | M39132 | |
| Coexpression | GSE13173_UNTREATED_VS_IL12_TREATED_ACT_CD8_TCELL_UP | 3.49e-04 | 129 | 28 | 3 | M464 | |
| Coexpression | GSE40274_FOXP3_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP | 3.98e-04 | 135 | 28 | 3 | M9141 | |
| Coexpression | SERVITJA_LIVER_HNF1A_TARGETS_UP | 4.16e-04 | 137 | 28 | 3 | M2397 | |
| Coexpression | DESCARTES_FETAL_THYMUS_STROMAL_CELLS | 4.16e-04 | 137 | 28 | 3 | M40313 | |
| Coexpression | GSE37605_TREG_VS_TCONV_NOD_FOXP3_FUSION_GFP_UP | 5.42e-04 | 150 | 28 | 3 | M8796 | |
| Coexpression | SERVITJA_LIVER_HNF1A_TARGETS_UP | 5.42e-04 | 150 | 28 | 3 | MM936 | |
| Coexpression | MURARO_PANCREAS_ENDOTHELIAL_CELL | 5.64e-04 | 362 | 28 | 4 | M39176 | |
| Coexpression | LIEN_BREAST_CARCINOMA_METAPLASTIC | 5.69e-04 | 33 | 28 | 2 | M11654 | |
| Coexpression | GROSS_ELK3_TARGETS_DN | 5.69e-04 | 33 | 28 | 2 | M1299 | |
| Coexpression | GSE36891_POLYIC_TLR3_VS_PAM_TLR2_STIM_PERITONEAL_MACROPHAGE_UP | 5.74e-04 | 153 | 28 | 3 | M8789 | |
| Coexpression | GSE40274_FOXP3_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP | 5.74e-04 | 153 | 28 | 3 | M9148 | |
| Coexpression | ZHANG_UTERUS_C4_MYOFIBROBLAST | 6.06e-04 | 369 | 28 | 4 | MM16610 | |
| Coexpression | DESCARTES_FETAL_ADRENAL_STROMAL_CELLS | 6.07e-04 | 156 | 28 | 3 | M40151 | |
| Coexpression | GROSS_ELK3_TARGETS_DN | 6.41e-04 | 35 | 28 | 2 | MM1124 | |
| Coexpression | GSE37605_TREG_VS_TCONV_NOD_FOXP3_FUSION_GFP_DN | 7.66e-04 | 169 | 28 | 3 | M8799 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 8.37e-04 | 40 | 28 | 2 | M5887 | |
| Coexpression | TRAVAGLINI_LUNG_VEIN_CELL | 8.37e-04 | 40 | 28 | 2 | M41663 | |
| Coexpression | ZHAN_MULTIPLE_MYELOMA_DN | 9.23e-04 | 42 | 28 | 2 | M2523 | |
| Coexpression | BROWNE_HCMV_INFECTION_18HR_DN | 9.49e-04 | 182 | 28 | 3 | M6641 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MID_AIRWAY_SMC_2_CELL | 1.06e-03 | 189 | 28 | 3 | M45678 | |
| Coexpression | AIZARANI_LIVER_C21_STELLATE_CELLS_1 | 1.14e-03 | 194 | 28 | 3 | M39122 | |
| Coexpression | DESCARTES_FETAL_SPLEEN_MESOTHELIAL_CELLS | 1.14e-03 | 194 | 28 | 3 | M40292 | |
| Coexpression | GSE15659_NAIVE_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_UP | 1.18e-03 | 196 | 28 | 3 | M3545 | |
| Coexpression | GSE15659_CD45RA_NEG_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_UP | 1.18e-03 | 196 | 28 | 3 | M3553 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | 1.19e-03 | 767 | 28 | 5 | M39209 | |
| Coexpression | GSE22025_UNTREATED_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_DN | 1.19e-03 | 197 | 28 | 3 | M8386 | |
| Coexpression | DESCARTES_FETAL_HEART_SMOOTH_MUSCLE_CELLS | 1.20e-03 | 48 | 28 | 2 | M40200 | |
| Coexpression | GSE21670_UNTREATED_VS_IL6_TREATED_CD4_TCELL_UP | 1.21e-03 | 198 | 28 | 3 | M7459 | |
| Coexpression | GSE46242_CTRL_VS_EGR2_DELETED_TH1_CD4_TCELL_UP | 1.23e-03 | 199 | 28 | 3 | M9705 | |
| Coexpression | GSE22935_24H_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_DN | 1.25e-03 | 200 | 28 | 3 | M7755 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_6H_DN | 1.25e-03 | 200 | 28 | 3 | M9933 | |
| Coexpression | GSE22935_UNSTIM_VS_24H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_DN | 1.25e-03 | 200 | 28 | 3 | M7771 | |
| Coexpression | GSE12392_IFNAR_KO_VS_IFNB_KO_CD8_NEG_SPLEEN_DC_DN | 1.25e-03 | 200 | 28 | 3 | M7136 | |
| Coexpression | GSE20715_0H_VS_24H_OZONE_TLR4_KO_LUNG_DN | 1.25e-03 | 200 | 28 | 3 | M4375 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPERIC | 1.39e-03 | 795 | 28 | 5 | M39050 | |
| Coexpression | BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP | 1.81e-03 | 59 | 28 | 2 | M10156 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 1.37e-06 | 445 | 28 | 7 | GSM777043_500 | |
| CoexpressionAtlas | Stromal Cells, LEC.SLN, gp38+ CD31+, Lymph Node, avg-4 | 1.48e-06 | 450 | 28 | 7 | GSM777063_500 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1 | ADAMTS16 ADAMTS10 ADAMTS15 SEMA5A HMCN1 SEMA5B ADAMTS9 ADAMTSL2 IGDCC4 | 1.18e-05 | 1166 | 28 | 9 | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1 |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 1.88e-05 | 437 | 28 | 6 | GSM777046_500 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 2.70e-05 | 466 | 28 | 6 | GSM777050_500 | |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 3.00e-05 | 281 | 28 | 5 | PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05 | 3.00e-05 | 281 | 28 | 5 | PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | dev gonad_e13.5_M_SertoliCell_Sox9_k-means-cluster#2_top-relative-expression-ranked_200 | 3.63e-05 | 49 | 28 | 3 | gudmap_dev gonad_e13.5_M_SertoliCell_Sox9_k2_200 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | 4.80e-05 | 768 | 28 | 7 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | 5.88e-05 | 793 | 28 | 7 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#2_top-relative-expression-ranked_1000 | 7.37e-05 | 62 | 28 | 3 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k2_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#2_top-relative-expression-ranked_1000 | 9.50e-05 | 184 | 28 | 4 | gudmap_developingLowerUrinaryTract_P1_ureter_1000_k2 | |
| CoexpressionAtlas | BM Top 100 - lymph nodes | 9.72e-05 | 68 | 28 | 3 | BM Top 100 - lymph nodes | |
| CoexpressionAtlas | BM Top 100 - ovary | 1.06e-04 | 70 | 28 | 3 | BM Top 100 - ovary | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.10e-04 | 191 | 28 | 4 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k4_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_top-relative-expression-ranked_500 | 2.04e-04 | 422 | 28 | 5 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.20e-04 | 229 | 28 | 4 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_1000_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_k-means-cluster#2_top-relative-expression-ranked_100 | 2.25e-04 | 17 | 28 | 2 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_100_k2 | |
| CoexpressionAtlas | kidney_adult_RenCorpuscGlomer_k-means-cluster#2_top-relative-expression-ranked_100 | 2.25e-04 | 17 | 28 | 2 | gudmap_kidney_adult_RenCorpuscGlomer_k2_100 | |
| CoexpressionAtlas | Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4 | 2.45e-04 | 439 | 28 | 5 | GSM777059_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_SupCellPrec_Sry_k-means-cluster#1_top-relative-expression-ranked_500 | 2.79e-04 | 97 | 28 | 3 | gudmap_dev gonad_e11.5_M_SupCellPrec_Sry_k1_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_SupCellPrec_Sry_k-means-cluster#3_top-relative-expression-ranked_100 | 2.83e-04 | 19 | 28 | 2 | gudmap_dev gonad_e11.5_M_SupCellPrec_Sry_k3_100 | |
| CoexpressionAtlas | dev gonad_e11.5_M_SupCellPrec_Sry_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.12e-04 | 251 | 28 | 4 | gudmap_dev gonad_e11.5_M_SupCellPrec_Sry_k3_1000 | |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_200 | 3.81e-04 | 22 | 28 | 2 | gudmap_kidney_P0_CapMes_Crym_k4_200 | |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_500 | 4.25e-04 | 495 | 28 | 5 | JC_hmvEC_500 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#3 | 4.31e-04 | 1094 | 28 | 7 | ratio_EB_vs_SC_2500_K3 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | 4.48e-04 | 778 | 28 | 6 | gudmap_developingGonad_e18.5_ovary_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_k-means-cluster#4_top-relative-expression-ranked_1000 | 4.59e-04 | 115 | 28 | 3 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_k4_1000 | |
| CoexpressionAtlas | DevelopingGonad_P2_testes_emap-30171_k-means-cluster#2_top-relative-expression-ranked_500 | 4.83e-04 | 117 | 28 | 3 | gudmap_developingGonad_P2_testes_500_k2 | |
| CoexpressionAtlas | dev gonad_e12.5_M_SertoliCell_Sox9_k-means-cluster#1_top-relative-expression-ranked_100 | 4.94e-04 | 25 | 28 | 2 | gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_k1_100 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_k-means-cluster#4_top-relative-expression-ranked_1000 | 5.60e-04 | 293 | 28 | 4 | gudmap_developingGonad_e18.5_testes_1000_k4 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_top-relative-expression-ranked_1000 | 5.69e-04 | 814 | 28 | 6 | gudmap_developingGonad_e18.5_testes_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4 | 5.76e-04 | 1148 | 28 | 7 | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_top-relative-expression-ranked_1000 | 7.11e-04 | 849 | 28 | 6 | gudmap_dev gonad_e11.5_M_GonMes_Sma_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_k-means-cluster#4_top-relative-expression-ranked_200 | 7.13e-04 | 30 | 28 | 2 | gudmap_dev gonad_e11.5_F_GonMes_Sma_k4_200 | |
| CoexpressionAtlas | dev gonad_e12.5_M_SertoliCell_Sox9_k-means-cluster#4_top-relative-expression-ranked_500 | 7.81e-04 | 138 | 28 | 3 | gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_k4_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#4_top-relative-expression-ranked_1000 | 7.81e-04 | 138 | 28 | 3 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k4_1000 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#1_top-relative-expression-ranked_1000 | 8.12e-04 | 32 | 28 | 2 | gudmap_kidney_adult_RenalCapsule_k1_1000 | |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_k-means-cluster#2_top-relative-expression-ranked_500 | 9.16e-04 | 34 | 28 | 2 | gudmap_kidney_P2_CapMes_Crym_k2_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#4_top-relative-expression-ranked_1000 | 9.38e-04 | 147 | 28 | 3 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k4_1000 | |
| CoexpressionAtlas | kidney_adult_RenCorpuscGlomer_k-means-cluster#4_top-relative-expression-ranked_1000 | 9.57e-04 | 148 | 28 | 3 | gudmap_kidney_adult_RenCorpuscGlomer_k4_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_M_SupCellPrec_Sry_k-means-cluster#3_top-relative-expression-ranked_200 | 1.03e-03 | 36 | 28 | 2 | gudmap_dev gonad_e11.5_M_SupCellPrec_Sry_k3_200 | |
| CoexpressionAtlas | placenta | 1.08e-03 | 349 | 28 | 4 | placenta | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.09e-03 | 155 | 28 | 3 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k1_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.20e-03 | 160 | 28 | 3 | gudmap_developingGonad_e18.5_ovary_1000_k4 | |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_k-means-cluster#1_top-relative-expression-ranked_500 | 1.27e-03 | 40 | 28 | 2 | gudmap_kidney_P0_CapMes_Crym_k1_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_top-relative-expression-ranked_200 | 1.29e-03 | 164 | 28 | 3 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_200 | |
| CoexpressionAtlas | kidney_adult_Mesangium_Meis_top-relative-expression-ranked_200 | 1.35e-03 | 167 | 28 | 3 | gudmap_kidney_adult_Mesangium_Meis_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_2500_k-means-cluster#2 | 1.37e-03 | 642 | 28 | 5 | Facebase_RNAseq_e9.5_Facial Mesenchyne_2500_K2 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500 | 1.37e-03 | 373 | 28 | 4 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_DevVasOvary_Flk_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.40e-03 | 42 | 28 | 2 | gudmap_dev gonad_e12.5_F_gudmap_devVasOvary_Flk_k4_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_SertoliCell_Sox9_top-relative-expression-ranked_200 | 1.43e-03 | 170 | 28 | 3 | gudmap_dev gonad_e13.5_M_SertoliCell_Sox9_200 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_k-means-cluster#3_top-relative-expression-ranked_200 | 1.46e-03 | 43 | 28 | 2 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_200_k3 | |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_1000 | 1.58e-03 | 990 | 28 | 6 | JC_hmvEC_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_SertoliCell_Sox9_top-relative-expression-ranked_200 | 1.60e-03 | 177 | 28 | 3 | gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_200 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#3_top-relative-expression-ranked_500 | 1.60e-03 | 45 | 28 | 2 | gudmap_developingGonad_e16.5_epididymis_500_k3 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ testes_emap-6710_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.71e-03 | 181 | 28 | 3 | gudmap_developingGonad_e14.5_ testes_1000_k2 | |
| CoexpressionAtlas | lung | 1.73e-03 | 182 | 28 | 3 | lung | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.73e-03 | 182 | 28 | 3 | gudmap_developingGonad_e16.5_ovary_1000_k1 | |
| CoexpressionAtlas | dev gonad_e11.5_F_ReproVasc_Flk_k-means-cluster#3_top-relative-expression-ranked_500 | 1.90e-03 | 49 | 28 | 2 | gudmap_dev gonad_e11.5_F_ReproVasc_Flk_k3_500 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_500 | 1.91e-03 | 408 | 28 | 4 | gudmap_kidney_adult_RenalCapsule_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_ReproVasc_Flk_top-relative-expression-ranked_500 | 1.93e-03 | 409 | 28 | 4 | gudmap_dev gonad_e11.5_F_ReproVasc_Flk_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_top-relative-expression-ranked_500 | 1.98e-03 | 412 | 28 | 4 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.11cloSer.Salm3.SI, CD45+ MHCII+ Gr1- CD11c-lo CD11b+, Small Intestine, avg-4 | 2.22e-03 | 53 | 28 | 2 | GSM854276_100 | |
| CoexpressionAtlas | kidney_adult_Mesangium_Meis_top-relative-expression-ranked_500 | 2.29e-03 | 429 | 28 | 4 | gudmap_kidney_adult_Mesangium_Meis_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_500 | 2.30e-03 | 201 | 28 | 3 | gudmap_developingKidney_e15.5_500_k3 | |
| CoexpressionAtlas | dev gonad_e13.5_F_SupCellPrec_Sry_k-means-cluster#1_top-relative-expression-ranked_500 | 2.30e-03 | 54 | 28 | 2 | gudmap_dev gonad_e13.5_F_SupCellPrec_Sry_k1_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_SertoliCell_Sox9_top-relative-expression-ranked_500 | 2.37e-03 | 433 | 28 | 4 | gudmap_dev gonad_e13.5_M_SertoliCell_Sox9_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_SertoliCell_Sox9_top-relative-expression-ranked_500 | 2.53e-03 | 441 | 28 | 4 | gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_ReproVasc_Flk_k-means-cluster#2_top-relative-expression-ranked_500 | 2.65e-03 | 58 | 28 | 2 | gudmap_dev gonad_e11.5_M_ReproVasc_Flk_k2_500 | |
| ToppCell | COVID-19-Heart-Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.67e-11 | 181 | 28 | 7 | 33cac65ed1ea5e7bd72250495df4f850b143d5aa | |
| ToppCell | COVID-19-Heart-Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.88e-11 | 184 | 28 | 7 | 21790cdfa3b4036ad413fd44b94e31563116f25f | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.03e-11 | 186 | 28 | 7 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 2.44e-11 | 191 | 28 | 7 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.63e-11 | 193 | 28 | 7 | 000b9e6a819b94ea2e6e9173daf97ba9ac2b6cc6 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.63e-11 | 193 | 28 | 7 | 261cafc167c86ab277be4ea7f08b0173e2dde26e | |
| ToppCell | Biopsy_IPF-Mesenchymal-PLIN2+_Fibroblasts|Biopsy_IPF / Sample group, Lineage and Cell type | 3.38e-11 | 200 | 28 | 7 | 2c5626ea8fb4b702d4560117e53edf6cfcf1971e | |
| ToppCell | Pericytes-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 1.37e-09 | 181 | 28 | 6 | ff445a8e56522e57e27405184d123cf905caf8cc | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.41e-09 | 182 | 28 | 6 | e67f3234165199085c793915ebb1f9bbd845e933 | |
| ToppCell | tumor_Lung-Fibroblasts-Pericytes|tumor_Lung / Location, Cell class and cell subclass | 1.46e-09 | 183 | 28 | 6 | a03dd563af9b15cb1f5de5732a229405a9f82d84 | |
| ToppCell | COVID-19-Fibroblasts-Pericytes|COVID-19 / group, cell type (main and fine annotations) | 1.56e-09 | 185 | 28 | 6 | 4905adaeeffd353e089578e5ea614437dbe794e6 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.61e-09 | 186 | 28 | 6 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.66e-09 | 187 | 28 | 6 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | 11.5-Airway-Mesenchymal-Pericyte|Airway / Age, Tissue, Lineage and Cell class | 1.71e-09 | 188 | 28 | 6 | 916971d8660fd20f616346953874e89d2cd13e88 | |
| ToppCell | background-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 2.34e-09 | 198 | 28 | 6 | bd11b0e9e80449aab979a02c1023e0638c431c7c | |
| ToppCell | background-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.34e-09 | 198 | 28 | 6 | 79f32f965aed6a10c5cb803173e3db7b32e07a91 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.41e-09 | 199 | 28 | 6 | aacd3ffa40a6e6f435aa9be5b959d88812eb69d4 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Smooth_muscle-1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.49e-09 | 200 | 28 | 6 | 43b76e382b38b9856c07557a75e5b1ce0cee1d9e | |
| ToppCell | Biopsy_IPF-Mesenchymal-HAS1_High_Fibroblasts|Biopsy_IPF / Sample group, Lineage and Cell type | 2.49e-09 | 200 | 28 | 6 | d02e256b5d65a5c982ba5696bc7e077281ca3e24 | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Smooth_muscle-1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 2.49e-09 | 200 | 28 | 6 | 78e9a40153d7ba5d9ea6393a37d26fc5c0220867 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Smooth_muscle-1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.49e-09 | 200 | 28 | 6 | c46e06b4f22d3456e67bc62a9ac198e8041965ad | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.09e-08 | 181 | 28 | 5 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | RA-07._Pericyte|World / Chamber and Cluster_Paper | 9.34e-08 | 182 | 28 | 5 | 2075efeae633550fb2eb026d0dfd741c8252482e | |
| ToppCell | LA-07._Pericyte|World / Chamber and Cluster_Paper | 9.60e-08 | 183 | 28 | 5 | e3835db4795362b0442d5893baf2a78efcc20428 | |
| ToppCell | COPD-Stromal-Pericyte|COPD / Disease state, Lineage and Cell class | 9.86e-08 | 184 | 28 | 5 | a56264a22dfc2d3672b20134ab7c3c7c23da5ae1 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.86e-08 | 184 | 28 | 5 | 327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b | |
| ToppCell | LA-07._Pericyte|LA / Chamber and Cluster_Paper | 1.01e-07 | 185 | 28 | 5 | ba5baa4d7f097108622674de5b7f4fd279843d24 | |
| ToppCell | COPD-Stromal-Pericyte|World / Disease state, Lineage and Cell class | 1.04e-07 | 186 | 28 | 5 | 8adfd2d1fda4e8aecc95192ea627bf7ed5214b8d | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.13e-07 | 189 | 28 | 5 | 9c2492c38f27e4c699b40680652e4c64911cce52 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteochondral_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.13e-07 | 189 | 28 | 5 | 1ff4f8da572bdc6356e9df9f41a7f62c81d4c570 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.13e-07 | 189 | 28 | 5 | d0c7549be4f77520c23dddf4f94d0fcad0081e37 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.16e-07 | 190 | 28 | 5 | 10125091ad648163777b02e9f0d5e8d7f17d44a5 | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.16e-07 | 190 | 28 | 5 | a21653bfb7bafbc273f94fa7c13bfb48cf8fd562 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.16e-07 | 190 | 28 | 5 | 0fea33f2dc1efa23aaa2da1c318482a52a313ff1 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.16e-07 | 190 | 28 | 5 | 4f775ee24b14733f06ae40b45f2dc1a0f0df0705 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.19e-07 | 191 | 28 | 5 | 5c4e4e9de14edfae072a2a2882220a31bebf51b2 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.19e-07 | 191 | 28 | 5 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | Mesenchymal-vascular_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 1.19e-07 | 191 | 28 | 5 | fd89fbc62aa1c73e0f659991e3bd726a0c97bd68 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-alveolar_fibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.19e-07 | 191 | 28 | 5 | 80484d39f34703a33b9bac09826b7a526e883cab | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.22e-07 | 192 | 28 | 5 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-07 | 192 | 28 | 5 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.22e-07 | 192 | 28 | 5 | 55f95454399fd533df75db06584eaa48d6ee3830 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-07 | 192 | 28 | 5 | 840a34c1b82d218be999ab5e1bcafd6370d7a4b1 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.22e-07 | 192 | 28 | 5 | 5000440dc1ed17e7474d340921bdff945646f27e | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.22e-07 | 192 | 28 | 5 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-07 | 193 | 28 | 5 | abdfb8b1dbdcb424042e21017a9e829fced4457e | |
| ToppCell | facs-Pancreas-Exocrine-3m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-07 | 193 | 28 | 5 | c3161a14a40323a58aa202c8a1d6ea0e9c2b9814 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-07 | 193 | 28 | 5 | 027e098ad018e782287f84eee0f77551018f2196 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.25e-07 | 193 | 28 | 5 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-07 | 193 | 28 | 5 | c5463a87f20b3a7f7ffda677b2f5a0e9e49d6685 | |
| ToppCell | RA|World / Chamber and Cluster_Paper | 1.28e-07 | 194 | 28 | 5 | 08f0afbb68a63150fbe107a5337299081c3f69e4 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.28e-07 | 194 | 28 | 5 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | 11.5-Distal-Mesenchymal-Pericyte|Distal / Age, Tissue, Lineage and Cell class | 1.28e-07 | 194 | 28 | 5 | 08701590496cf85ff790e54a81493c61177e76ff | |
| ToppCell | IPF-Stromal-Pericyte|World / Disease state, Lineage and Cell class | 1.28e-07 | 194 | 28 | 5 | 1a41da29d5adaf766a84eff0003b959e4523f7f1 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.28e-07 | 194 | 28 | 5 | 67f5e2f05a8de2213ab80d5ea16fdee121684633 | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-myofibroblast_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.32e-07 | 195 | 28 | 5 | c6bb16c0076639c6ddef1a15d8cba44bc29c077d | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Subpleural_fibroblasts-Subpleural_fibroblasts_L.2.1.5.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.32e-07 | 195 | 28 | 5 | 0866aaf053762d1a021fcbccff058526078a99da | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.32e-07 | 195 | 28 | 5 | ea89f80d3d7e9f737442f7c1aa1791d277ffc90c | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.32e-07 | 195 | 28 | 5 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | IPF-Stromal-Pericyte|IPF / Disease state, Lineage and Cell class | 1.35e-07 | 196 | 28 | 5 | 8b6ff47ce5291d223f5e639fc45cd9267f418256 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Subpleural_fibroblasts-Subpleural_fibroblasts_L.2.1.5.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.35e-07 | 196 | 28 | 5 | 46d665de09f8164690b9a3e0acf0b0afa3f81b3d | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.39e-07 | 197 | 28 | 5 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.39e-07 | 197 | 28 | 5 | 26475b9e4d6bfc0ae818dea13d139888ed7e92f1 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.39e-07 | 197 | 28 | 5 | 3f078be0b0f5e16edfb6d517beb20ac6178767f0 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.39e-07 | 197 | 28 | 5 | 155e63b33302a87393ace699b2f6d73abe9c5763 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.42e-07 | 198 | 28 | 5 | 637f11e292b90d86cdc0d0d828eb26f38289c25b | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Pericyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.42e-07 | 198 | 28 | 5 | 76d46950c11cb4708866db0da54ce00d5c0adab8 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.42e-07 | 198 | 28 | 5 | a4005a49cf6709b543994ceb51ecd5dc46197fa9 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.46e-07 | 199 | 28 | 5 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.46e-07 | 199 | 28 | 5 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.46e-07 | 199 | 28 | 5 | 0a145172787f40d0fdaf21188d539ffaf7ece3e4 | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.46e-07 | 199 | 28 | 5 | c2903b1a4b91e94bbdaa909bacefe901255cf248 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.46e-07 | 199 | 28 | 5 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.46e-07 | 199 | 28 | 5 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.49e-07 | 200 | 28 | 5 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.49e-07 | 200 | 28 | 5 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.49e-07 | 200 | 28 | 5 | 44a68bacdb3d5bf563bd35952176995850933a81 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.49e-07 | 200 | 28 | 5 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.49e-07 | 200 | 28 | 5 | 50ca6550998e461ef26dd670351060bd940765a8 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.49e-07 | 200 | 28 | 5 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.49e-07 | 200 | 28 | 5 | f692b602bc989d35c9162e73dda813dbef8d5267 | |
| ToppCell | Tracheal-NucSeq-Stromal-Pericyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.49e-07 | 200 | 28 | 5 | 78cd0b7d221ef855512ee9ac9a291f61622c2e24 | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.49e-07 | 200 | 28 | 5 | fc2fc3bfcf1ad9bfb9fe07bbed8068126930bee6 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.49e-07 | 200 | 28 | 5 | dc61016c61729f69649cfb21f6264e685ce83dea | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.49e-07 | 200 | 28 | 5 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.49e-07 | 200 | 28 | 5 | 1c10597edd532bf172ca09870a937d35e2585081 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Subpleural_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.49e-07 | 200 | 28 | 5 | d64895354218ebd0217011bae0967a6883bbd1cd | |
| ToppCell | distal-mesenchymal-Adventitial_Fibroblast|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.49e-07 | 200 | 28 | 5 | 687cfada2d0977e8985e0a73a5804f84f2ca9c52 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-2|TCGA-Bladder / Sample_Type by Project: Shred V9 | 1.07e-06 | 124 | 28 | 4 | ff08f74c3bc8e60679e0e21370095936a174c580 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Fibroblasts|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.74e-06 | 157 | 28 | 4 | f086753b51860e23f1275bd75e8802d2a7d7b70a | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.81e-06 | 158 | 28 | 4 | 8d64c0c9de910a3f4658778642d183c8b9b6f6a2 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-F-|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.41e-06 | 166 | 28 | 4 | 1cc291a04f4144abba4aca7badeb7776db05d903 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-F|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.41e-06 | 166 | 28 | 4 | 2887f4f0c218cbcbcc82eef27aa4ee714b35cddb | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 3.58e-06 | 168 | 28 | 4 | aefea14b8b1c1b6a05f827effd22ba15274fddc9 | |
| ToppCell | RA-01._Fibroblast_I|RA / Chamber and Cluster_Paper | 3.67e-06 | 169 | 28 | 4 | 6373562ab3b1765060212a6a53d6543e7e942e80 | |
| ToppCell | Control-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations) | 3.84e-06 | 171 | 28 | 4 | 080003f698f867935c2bfc55d241d3650f45a0ab | |
| ToppCell | Control-Stromal-Pericyte|World / Disease state, Lineage and Cell class | 3.93e-06 | 172 | 28 | 4 | 813d4256b05b66ca11b08cc0026459d79f12c0eb | |
| ToppCell | -Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 4.02e-06 | 173 | 28 | 4 | 88be9182fbb1bc83531cd41e59ea57c112a21d54 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.02e-06 | 173 | 28 | 4 | 5416b092321c7d9b63f0418c60f2402a138355bf | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.12e-06 | 174 | 28 | 4 | 015d3742d3d79a57413a333f00ef2d380a9848dd | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.14e-05 | 50 | 15 | 3 | GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_NF_KB | |
| Drug | chondroitin sulfate | ADAMTS16 SEMA5A THBS1 ADAMTS5 ADAMTS4 SEMA5B ADAMTS1 ADAMTS9 | 2.48e-08 | 413 | 28 | 8 | CID000024766 |
| Drug | AC1L1KGC | 7.36e-06 | 225 | 28 | 5 | CID000005486 | |
| Drug | angiogenesis inhibitor | 1.76e-05 | 128 | 28 | 4 | CID002812173 | |
| Drug | glucosamine 3-O-sulfate | 2.18e-05 | 6 | 28 | 2 | ctd:C065632 | |
| Drug | Glucosamine | 3.50e-05 | 311 | 28 | 5 | ctd:D005944 | |
| Drug | DB04780 | 5.34e-05 | 170 | 28 | 4 | CID005459389 | |
| Drug | Amyleine hydrochloride [532-59-2]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 9.28e-05 | 196 | 28 | 4 | 4169_UP | |
| Drug | Procainamide hydrochloride [614-39-1]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 9.46e-05 | 197 | 28 | 4 | 2618_UP | |
| Drug | Tridihexethyl chloride; Up 200; 11.4uM; PC3; HT_HG-U133A | 9.65e-05 | 198 | 28 | 4 | 5067_UP | |
| Disease | a disintegrin and metalloproteinase with thrombospondin motifs 5 measurement | 2.42e-06 | 3 | 27 | 2 | EFO_0008326 | |
| Disease | scoliosis (implicated_via_orthology) | 8.05e-06 | 5 | 27 | 2 | DOID:0060249 (implicated_via_orthology) | |
| Disease | degenerative disc disease (biomarker_via_orthology) | 4.41e-05 | 11 | 27 | 2 | DOID:90 (biomarker_via_orthology) | |
| Disease | vital capacity | 9.45e-05 | 1236 | 27 | 7 | EFO_0004312 | |
| Disease | type 2 diabetes mellitus (implicated_via_orthology) | 1.20e-04 | 105 | 27 | 3 | DOID:9352 (implicated_via_orthology) | |
| Disease | pulse pressure measurement | 1.98e-04 | 1392 | 27 | 7 | EFO_0005763 | |
| Disease | diastolic blood pressure, systolic blood pressure | 3.17e-04 | 670 | 27 | 5 | EFO_0006335, EFO_0006336 | |
| Disease | colorectal health | 8.07e-04 | 201 | 27 | 3 | EFO_0008460 | |
| Disease | mammographic density measurement | 9.61e-04 | 50 | 27 | 2 | EFO_0005941 | |
| Disease | obesity (implicated_via_orthology) | 9.81e-04 | 215 | 27 | 3 | DOID:9970 (implicated_via_orthology) | |
| Disease | Hepatomegaly | 1.12e-03 | 54 | 27 | 2 | C0019209 | |
| Disease | rheumatoid arthritis (is_marker_for) | 1.82e-03 | 69 | 27 | 2 | DOID:7148 (is_marker_for) | |
| Disease | brain volume measurement | 1.99e-03 | 595 | 27 | 4 | EFO_0006930 | |
| Disease | carpal tunnel syndrome | 3.01e-03 | 89 | 27 | 2 | EFO_0004143 | |
| Disease | Alzheimer disease, family history of Alzheimer’s disease | 5.30e-03 | 119 | 27 | 2 | EFO_0009268, MONDO_0004975 | |
| Disease | cup-to-disc ratio measurement | 6.93e-03 | 430 | 27 | 3 | EFO_0006939 | |
| Disease | colorectal cancer (is_marker_for) | 9.05e-03 | 157 | 27 | 2 | DOID:9256 (is_marker_for) | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 9.05e-03 | 157 | 27 | 2 | DOID:224 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LWSLWGECTRDCGGG | 266 | O14514 | |
| GSWGSWGQCSRSCGG | 571 | Q9UNA0 | |
| PWGPWGECSRTCGGG | 531 | Q9UP79 | |
| PAWLGAAAAGCWGWG | 76 | Q9HD20 | |
| GPWTPWGDCSRTCGG | 551 | Q9H324 | |
| ARWVAGSWGPCSASC | 841 | Q8TE58 | |
| DWSSWSPCSRTCGGG | 591 | Q8TE57 | |
| WSVGNWSACSRTCGG | 931 | Q8TE57 | |
| PSGLSWAGSWAGCEL | 1066 | Q8TDY8 | |
| SWGMWGPWGDCSRTC | 561 | Q9UHI8 | |
| SCRWSGSCGGWLPAG | 96 | Q9NVL1 | |
| CEAGGWAVRPGWSGA | 11 | P49286 | |
| CGWCAWGGQDGGGRC | 2136 | Q7Z7M0 | |
| WTVSDWGPCSGSCGQ | 741 | Q86TH1 | |
| WASWSACSVSCGGGA | 4706 | Q96RW7 | |
| SPWSGWGTCSRTCNG | 4761 | Q96RW7 | |
| GGRGTPKDGTDWCCW | 51 | P39877 | |
| WGPWGDCSRTCGGGV | 526 | O75173 | |
| WGSWSPFGTCSRTCG | 591 | Q9P2N4 | |
| NSWRCDCGLGPFLGW | 421 | P40197 | |
| SCRWSGSCGGWLPAG | 96 | A6NEL3 | |
| DCTSAGRSDGWLWCG | 181 | P22897 | |
| SLWSSWGLCGGHCGR | 281 | Q9BUD6 | |
| PWSVWSSCSRSCGLG | 2506 | A2VEC9 | |
| MWEAWGPCSVSCGGG | 2561 | A2VEC9 | |
| GGCPLPCGWSAWSSW | 2711 | A2VEC9 | |
| AWSSWAPCDRSCGSG | 2721 | A2VEC9 | |
| WGPWGPWSHCSRSCG | 3256 | A2VEC9 | |
| SWGPWEDCSVSCGGG | 3651 | A2VEC9 | |
| GPGCGAGNCSWTSWA | 3941 | A2VEC9 | |
| RWSPWSWCDRSCGGG | 4011 | A2VEC9 | |
| WSSWSDCPVSCGGGN | 4261 | A2VEC9 | |
| PWSAWSSCSAPCGGG | 4771 | A2VEC9 | |
| CWGGPCSSALRCGWF | 71 | Q9UK53 | |
| CWSPWTKCSATCGGG | 846 | Q13591 | |
| GPWSPWDICSVTCGG | 496 | P07996 | |
| PWSQWSPCSRTCGGG | 31 | O95428 | |
| WKAGPWAPCSASCGG | 366 | O95428 | |
| ASWGSWSKCSSNCGG | 726 | Q9P283 | |
| WTSWSPCSASCGGGH | 916 | Q9P283 | |
| WGDWSDCSRTCGGGA | 81 | P82987 | |
| RWHVGSWGPCSATCG | 706 | P82987 |